First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke
Go back to First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke| (NYSE: PEN) | Delayed: 317.90 +1.40 (0.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $316.50 | 52 Week High | $79.49 | |||
| Open | $315.70 | 52 Week Low | $40.23 | |||
| Day High | $317.95 | P/E | N/A | |||
| Day Low | $315.70 | EPS | $0.00 | |||
| Volume | 690,840 | |||||
